PEBC MCQ study guide: Drug Stability, Cold Chain & Hazardous Handling

Providing Care – Distribution

Storage temperature ranges, cold chain excursions, USP <800> hazardous handling, and Health Canada recall classes.

Standard Storage Temperature Ranges

Canadian/USP-aligned storage categories the exam expects memorized cold:

Room temperature (controlled): 15–30°C (commonly cited as 20–25°C for "controlled room temperature" with excursions permitted 15–30°C)
Refrigerator: 2–8°C
Freezer: -25°C to -10°C
Some biologics/vaccines have narrower "do not freeze" ranges specifically (e.g., many vaccines are refrigerated 2–8°C and destroyed if inadvertently frozen, since freezing can denature the protein/antigen structure)

Light-sensitive products require protection from light (amber packaging/vials, storage away from direct light) independent of temperature requirements — these are separate storage considerations that can both apply to the same product.

Cold Chain Excursion Protocol

A cold chain excursion (a refrigerated/frozen product found outside its required temperature range, e.g., after a power outage or transport delay) does NOT automatically mean the product must be discarded — the correct first step is to quarantine the affected product (physically separate and clearly label "do not use" pending assessment) and contact the manufacturer or use validated stability data to determine whether the specific excursion (duration, temperature reached, specific product) falls within an acceptable range. Automatically discarding without this assessment step, or continuing to use it without any assessment, are both incorrect — quarantine-then-assess is the tested correct sequence.

For vaccines specifically, provincial/territorial immunization programs maintain manufacturer-specific stability charts precisely for this purpose (many common vaccines tolerate brief excursions without loss of potency, but the exact tolerance is product-specific and must be confirmed, not assumed).

Hazardous Drug Handling (NIOSH / USP <800>-Aligned)

Hazardous drugs (most chemotherapy agents, and select non-chemo drugs meeting NIOSH hazard criteria — teratogenic, carcinogenic, or reproductively toxic at low doses) require specific handling controls throughout the medication-use process, not only during compounding: dedicated storage (often negative-pressure, separate from general stock), personal protective equipment for anyone handling intact hazardous packaging (not just those compounding it), spill kits readily available, and designated hazardous waste disposal streams distinct from general pharmaceutical waste.

Personnel who are pregnant, breastfeeding, or actively trying to conceive are generally advised to avoid handling hazardous drugs due to reproductive toxicity risk — a workplace policy/accommodation point that appears on the exam under both safety and ethics/professionalism framing.

Health Canada Recall Classes

Health Canada classifies drug recalls by the severity of health risk, and the exam expects the relative ordering and what each implies for pharmacy action:

Type/Class I: reasonable probability of SERIOUS adverse health consequences or death — most urgent, immediate action required (pull from stock/shelf immediately, notify affected patients if already dispensed).
Type/Class II: may cause temporary or medically reversible adverse health consequences, or where the probability of serious harm is remote — action required but less immediately urgent than Class I.
Type/Class III: unlikely to cause any adverse health consequence (e.g., minor labelling defect) — lowest urgency, often just a stock correction.

Regardless of class, the pharmacy's standard response pattern is: identify and quarantine affected lot/stock immediately upon notification, check dispensing records to identify any patients who received affected product, and follow the specific manufacturer/Health Canada recall notice instructions for that class (which may include patient notification, return-to-manufacturer, or destruction).

High-yield points

Memorize cold: room temp 15–30°C, fridge 2–8°C, freezer -25 to -10°C — and that many vaccines must never be frozen even though they're fridge-stored.
Cold chain excursion = quarantine THEN assess (manufacturer/stability data) — never auto-discard, never auto-continue-using without assessment.
USP <800>-aligned hazardous handling applies to anyone handling intact hazardous packaging, not just the person compounding — and extends to pregnant/breastfeeding/conceiving staff avoiding handling.
Health Canada recall Type I = serious harm/death risk, most urgent; Type II = temporary/reversible harm; Type III = unlikely any harm (e.g., labelling defect).

Guideline references

USP General Chapter <800> — Hazardous Drugs Handling in Healthcare Settings
NIOSH List of Hazardous Drugs
Health Canada Recalls and Safety Alerts Database
Canadian National Vaccine Storage and Handling Guidelines